| Name | Title | Contact Details |
|---|
Katahdin Industries provides high-tolerance coating applications and specialized metal-finishing technology and services to the medical device and industrial markets through platform-focused subsidiaries including DCHN, Precision Coating, Medi-Solve Coatings and Sanford Process. Headquartered in Dedham, Mass., with operations in Woonsocket, R.I., Katahdin has earned an industry reputation as an innovative, high-quality supplier. Katahdin's technical and product development expertise, strong facilities and problem-solving culture have resulted in a track record of successful service performance for its customers. Each subsidiary is an expert provider of the services it offers. But mastery of the technology is only part of our competitive differentiation. Developing unique capabilities to handle specific applications, whether coating medical wire or finishing orthopedic equipment, allows us to provide these and other related services at a superior quality level and lower cost than other service providers. Katahdin's coating operations are conducted through Precision Coating Company, Inc., one of the largest plastics coating applicators in the world, specializing in PTFE and Teflon® coating applications in the medical device market. A separate co-located company, Precision Fabric, is a worldwide distributor and converter of PTFE-coated fabrics, tapes and belts. Specialized metal finishing services are conducted through DCHN, LLC, an industry leader in technical aluminum and titanium anodizing, electro-polish and passivation, and other related services. Sanford Process Corporation provides hard-coat anodizing solutions, as well as licenses the company's intellectual property, to a range of well-known OEMs and their prime subcontractors worldwide, with an increasing presence in Korea and China. Katahdin seeks to acquire expert service providers and formulators with a strong history of innovation, current facilities, dedicated customer service, and high-quality management. The company's acquisition strategy is flexible, offering the potential for owners to retain a stake in the business. By leveraging Katahdin's capabilities, acquired companies are able to increase growth and profitability by focusing on their customers and technology needs while expanding sales and marketing reach.
RyMed Technologies is a Mobile, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DKBmed is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
Eppendorf AG is a leading supplier of systems and research tools for the biotechnology industry worldwide with a wide range of products including instruments, consumables and reagents. Applications include cell manipulation, complete PCR systems, liquid